Amgen Sensipar Approved; Target U.S. Market At Least 300,000 Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Cinacalcet is indicated for the treatment of hyperparathyroidism associated with kidney disease and hypercalcemia in parathyroid cancer patients.